Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location |
|---|---|---|---|
An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients. |
Resistant Hypertension | Phase 2 | United States Australia Netherlands China Spain Slovakia Germany France Italy Czech Republic Austria Japan United Kingdom Poland Taiwan Bulgaria View All |
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma |
Asthma | Phase 3 | Greece Spain South Africa Italy Romania Argentina Hungary Austria Mexico Guatemala Colombia Portugal Czech Republic View All |
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases |
Myeloid Diseases | Phase 1 | United States Italy Germany France Hong Kong Spain Singapore View All |
Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera |
Polycythemia Vera | Italy | |
A Study of Safety and Efficacy of KFA115 Alone and in Combination With Pembrolizumab in Patients With Select Advanced Cancers |
Carcinoma, Non-Small-Cell Lung, Cutaneous Melanoma, Carcinoma, Renal Cell, Carcinoma, Ovarian Epithelial, Nasopharyngeal Carcinoma, Carcinoma, Thymic, Anal Cancer, Mesothelioma, Esophagogastric Cancer, High Microsatellite Instability Colorectal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms | Phase 1 | United States Spain Japan Germany Hong Kong Singapore Taiwan Canada View All |
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies |
Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Follicular Lymphoma | Brazil | |
A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery. |
Acute Kidney Injury Following Cardiac Surgery | Phase 2 | Germany Spain Hungary Argentina Brazil Lithuania Belgium France Czech Republic Singapore Taiwan Estonia View All |
An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib |
Chronic Spontaneous Urticaria | Phase 3 | United States Puerto Rico France Turkey Germany Colombia Poland Argentina Canada South Africa United Kingdom Denmark Hungary Japan China Korea, Republic of Italy Slovakia Czech Republic Brazil View All |
To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF |
Idiopathic Pulmonary Fibrosis | Phase 2 | United States Netherlands Poland Argentina Australia Germany Czech Republic View All |
A Proof-of-concept Study to Examine QUC398 in Participants With Knee OA |
Osteoarthritis, Knee | Phase 2 | United States Spain Australia Denmark France View All |